FDA Talks Regenerative Medicine Advanced Therapy Designation
By EsqSocial Corporation 07/06/21
At the Food and Drug Law Institute’s 2021 annual conference, Dr. Peter Marks, the director of FDA’s Center for Biologics Evaluation and Research, commented on progress that has been made using FDA’s Regenerative Medicine Advanced Therapy (RMAT) designation....
By: Morgan Lewis - As Prescribed